A Study to Assess the Efficacy, Safety,and Tolerability of CAT-354

NCT ID: NCT00640016


Title
A Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of CAT-354
Purpose
To investigate the effects of CAT-354 on airway hyperresponsiveness (AHR) in uncontrolled asthma.
Details
Conditions
Asthma
Keywords
Source
MedImmune LLC
Sponsors
MedImmune LLC, Cambridge Antibody Technology, PRA Health Sciences
Status
Terminated
Acronym
Last Updated
10 Sep 2012
URL
Official Link
Locations
Australia, Germany, Netherlands, Poland, United Kingdom